IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1101-1125 out of 1297.

<< < 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>

Public Release: 3-Dec-2015
Cell Reports
Spreading cancer cells must change their environment to grow
Spreading cancer cells arriving in a new part of the body must be able to change their new environment to continue to grow.

Contact: Press Office
press.office@cancer.org.uk
020-346-98300
Cancer Research UK

Public Release: 2-Dec-2015
Nature
Researchers unravel age-old mystery of why cells use fermentation
Wine, beer and yogurt are produced when microorganisms convert sugar into alcohol, gases or acids. But this process of fermentation -- which is used by bacteria, fungi and other fast-growing cells to generate energy in the absence of oxygen -- is a much less efficient way of generating energy for cells than aerobic respiration. So why do many organisms use this seemingly wasteful strategy to generate energy instead of aerobic respiration, even when oxygen is readily available?
National Institutes of Health, Simons Foundation, Walter Haefner Foundation, ETH Foundation

Contact: Kim McDonald
kmcdonald@ucsd.edu
858-534-7572
University of California - San Diego

Public Release: 2-Dec-2015
Journal of Pathology
Researchers develop antibody to save cancerous bones
Osteosarcoma is a rare cancer most often affecting adolescents and children. While most bone cancers have their origin in other body tissues and spread to the bones through metastases, OS originates in the bone tissue. At the Finsen Laboratory, University of Copenhagen researchers now shows that OS cells degrade the bone tissue through a completely different process than metastasized bone cancer. Through treatment with a specific antibody, the researchers blocked the process and reduced up to 80 percent of bone degradation in a cancer model.
Danish Medical Research Council, Danish Cancer Society, Novo Nordisk Foundation, Lundbeck Foundation, Danish National Research Foundation under the programme Danish-Chinese Centre for Proteases and Cancer

Contact: Niels Behrendt
niels.behrendt@bric.ku.dk
0045-21-43-12-63
University of Copenhagen, Biotech Research & Innovation Centre

Public Release: 2-Dec-2015
Proceedings of the National Academy of Sciences
Studying stonefish venom may help combat transplant rejection
Monash University researchers have solved the X-ray crystal structure of the lethal factor present in stonefish venom. The discovery has provided unexpected insight into a crucial human immune response that is responsible for the failure of up to 30 percent of bone marrow transplant therapies for treating leukemia.

Contact: Alexia Lyons
alexia.lyons@monash.edu
Monash University

Public Release: 2-Dec-2015
Nature Communications
Liquid metal 'nano-terminators' target cancer cells
Researchers have developed a new drug delivery technique that uses a biodegradable liquid metal to target cancer cells. The liquid metal drug delivery method promises to boost the effect of cancer drugs.
National Institutes of Health, National Science Foundation

Contact: Matt Shipman
matt_shipman@ncsu.edu
919-515-6386
North Carolina State University

Public Release: 2-Dec-2015
RSNA 2015 101st Scientific Assembly and Annual Meeting
Study suggests breast density alone not a risk factor for cancer
Breast density may not be a strong independent factor for breast cancer risk, according to a new study.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 2-Dec-2015
PLOS ONE
RNA mystery solved in triple negative breast cancer
Researchers at Thomas Jefferson University have discovered why conventional efforts to block a tiny strand of ribonucleic acid, called microRNA, in triple negative breast cancer cells failed.

Contact: Colleen A Cordaro
colleen.cordaro@jefferson.edu
215-955-2238
Thomas Jefferson University

Public Release: 2-Dec-2015
Laboratory Investigation
Genetic mutations differ within a single tumor, study finds
When researchers looked at different areas within an individual rectal cancer sample, they found cases in which each area contained different genetic mutations. The findings could have significant implications for treatment recommendations.
NIH/National Cancer Institute, American Surgical Association Foundation Fellowship

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 2-Dec-2015
Cancer Epidemiology, Biomarkers & Prevention
False-positive mammograms may indicate increased risk of breast cancer later
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after the false-positive result.
Breast Cancer Surveillance Consortium, National Institutes of Health

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research

Public Release: 2-Dec-2015
Crop Science
Fries with a side of acrylamide
French fry lovers, beware! You may be exposed to a chemical more commonly associated with heavy industry than crispy fried potatoes. Fortunately, researchers are finding ways to reduce that exposure.
US Potato Board, Cavendish Foods, ConAgra Lamb-Weston, J.R. Simplot, McCain Foods, National Institute of Food and Agriculture USDA Specialty Crop Research Initiative

Contact: Susan Fisk
sfisk@sciencesocieties.org
608-273-8091
American Society of Agronomy

Public Release: 2-Dec-2015
European Radiology
Breast density alone found not to be a factor for breast cancer risk
Although several studies suggest that women with denser breast tissue have an increased risk of breast cancer, a new study by Johns Hopkins researchers discredits breast density as a risk factor in and of itself.
NIH/National Cancer Institute

Contact: Marin Hedin
mhedin2@jhmi.edu
410-502-9429
Johns Hopkins Medicine

Public Release: 2-Dec-2015
57th ASH Annual Meeting & Exposition
City of Hope researchers present study results at American Society of Hematology meeting
Clinical trials that lay the groundwork for novel leukemia and lymphoma treatments will be among the highlights of the annual meeting of the American Society of Hematology (ASH) getting under way this week in Orlando. The trials, presented by researchers and physicians from City of Hope, could ultimately lead to innovative therapeutic approaches that improve survival and quality of life for patients with those and other diseases.

Contact: Letisia Marquez
media@coh.org
800-888-5323
City of Hope

Public Release: 2-Dec-2015
57th ASH Annual Meeting & Exposition
Sylvester presents latest cancer research at ASH Annual Meeting
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine will present a selection of the latest advances in hematology research at this year's American Society of Hematology Annual Meeting, Dec. 5-8, at the Orange County Convention Center in Orlando, Fla.

Contact: Patrick Bartosch
patrick.bartosch@med.miami.edu
201-469-6408
University of Miami Miller School of Medicine

Public Release: 2-Dec-2015
Structure
New studies create better understanding of cancer-spreading enzymes
Researchers at the University of Missouri have determined a detailed structural view of one of these enzymes, called MMP7, as it binds to the membranes, or surfaces, of cancer cells. This understanding could lead to better treatments for cancer.
National Institutes of Health, Burroughs Wellcome Fund Career Award at the Scientific Interface

Contact: Nathan Hurst
hurstn@missouri.edu
573-882-6217
University of Missouri-Columbia

Public Release: 2-Dec-2015
Scientific Reports
Scientists design a new method for screening cancer cells
UCLA life scientists and colleagues today present a new method they developed to screen cancer cells and identify small molecules that can make cancer cells less lethal.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Public Release: 2-Dec-2015
The Journal of Alternative and Complementary Medicine
New study shows high use of complementary therapies by cancer inpatients
Patients hospitalized for cancer treatment commonly use complementary and integrative health (CIH) approaches such as nutritional supplements, special diets, and massage according to a new study. More than 95 percent of patients expressed interest in at least one of these types of therapies if offered during their hospital stay, as reported in the article published in The Journal of Alternative and Complementary Medicine.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 1-Dec-2015
Cancer
Men who forgo aggressive treatment for prostate cancer don't receive appropriate monitoring
An increasing number of men diagnosed with low-risk prostate cancer are opting for active surveillance -- closely monitoring their cancer -- rather than aggressive treatment to avoid the debilitating potential side effects of surgery and radiation.

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-794-2262
University of California - Los Angeles Health Sciences

Public Release: 1-Dec-2015
Siberian Journal of Oncology
Chemotherapy can cause tumor evolution
Russian scientists have found that neoadjuvant chemotherapy in patients with breast cancer can stimulate evolution of the tumor. The results of the research conducted by Nicholay Litvyakov, D.Sc. at Cancer Research Institute, Head of the Tumor Virology Laboratory, and TSU researcher Marina Ibragimova, were published in 'Siberian Journal of Oncology.'

Contact: Tatiana Arsenyeva
iro2@mail.tsu.ru
National Research Tomsk State University

Public Release: 1-Dec-2015
Bulletin of the World Health Organization
Poor countries are hardest hit by tobacco marketing
People living in poor countries are exposed to more intense and aggressive tobacco marketing than those living in affluent countries, according to a study published in the Bulletin of the World Health Organization today. Tobacco marketing, which drives the uptake of smoking especially among young people, is still thriving despite many countries' efforts to ban it, the study shows.

Contact: Fiona Fleck
fleckf@who.int
41-227-911-897
Bulletin of the World Health Organization

Public Release: 1-Dec-2015
Journal of National Cancer Institute
Taking antidepressants with cancer drug does not increase breast-cancer recurrence
A large study of patients with breast cancer who took the anti-cancer drug tamoxifen while taking an antidepressant were not found to have an increased risk of recurrence, according to a Kaiser Permanente study published in The Journal of the National Cancer Institute.
National Institutes of Health, California Breast Cancer Research Program

Contact: Navneet Miller
navneet.miller@creation.io
415-262-5972
Kaiser Permanente

Public Release: 1-Dec-2015
ecancermedicalscience
How does your garden grow? For cancer patients, small gardens could bring big benefits
Nature is full of benefits for the cancer patients, but it isn't always accessible. In the latest article in ecancermedicalscience, a team of researchers led by Dr Ceri Phelps of the University of Wales Trinity Saint David, Swansea, Wales decided to test a simpler, smaller approach -- accessible, cheap, and not prone to whims of weather.

Contact: Audrey Nailor
audrey@ecancer.org
44-117-403-3093
ecancermedicalscience

Public Release: 1-Dec-2015
Journal of Clinical Oncology
Complete surgical excision is the most effective treatment for breast implant-associated anaplastic large-cell lymphoma
he optimal treatment approach for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is complete surgical excision of the implant and surrounding capsule, according to an international study led by researchers at The University of Texas MD Anderson Cancer Center.

Contact: Clayton R. Boldt, Ph.D.
crboldt@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center

Public Release: 1-Dec-2015
Breast Cancer Research and Treatment
Cognitive-behavioral stress management in breast cancer
Newly published research from a National Cancer Institute-funded randomized trial shows that women who were provided with skills to manage stress early in their breast cancer treatment show greater length of survival and longer time till disease recurrence over eight to 15 years after their original diagnosis.
NIH/National Cancer Institute

Contact: Megan Ondrizek
m.ondrizek@umiami.edu
305-284-3667
University of Miami

Public Release: 1-Dec-2015
Lancet Oncology
A risk management plan for functional imaging in cancer clinical trials
In cancer clinical trials, we are always trying to strike the right balance between maximizing data quality and minimizing cost. Here, risk management can be an extremely helpful tool, because it can help us to prioritize, reduce costs, and decrease attrition rates. In our study, we used a quality risk management approach to help us outline a consensus framework for imaging biomarker driven trials.

Contact: John Bean
john.bean@eortc.be
European Organisation for Research and Treatment of Cancer

Public Release: 1-Dec-2015
Journal of Clinical Oncology
Stopping ovarian cancer in its tracks: An antibody may help patients heal themselves
In a first, Kyoto University shows the potential a PD-1 antibody, nivolumab, has in fighting the disease.
Health and Labour Sciences Research Grant, Translational Research Network Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, Kyoto University

Contact: Anna Ikarashi
comms@mail2.adm.kyoto-u.ac.jp
075-753-5728
Kyoto University

Showing releases 1101-1125 out of 1297.

<< < 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>

  Search News Releases

     

 

EurekAlert!